Skip to main content
Clinical Trials/TCTR20240321001
TCTR20240321001
Recruiting
Phase 2

Assessment of physical performance using walking test application Six minute walk test for physical performance evaluation in Coronary heart disease, Chronic kidney disease, Chronic Obstruction Pulmonary Disease and Stroke patients

/A0 sites100 target enrollmentMarch 21, 2024

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Coronary heart disease, Chronic kidney disease, Chronic Obstruction Pulmonary Disease and Stroke patients
Sponsor
/A
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 21, 2024
End Date
August 23, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • Coronary heart disease, Chronic kidney disease, Chronic Obstruction Pulmonary Disease and Stroke patients

Exclusion Criteria

  • unable to walk high blood pressure over 180/100 mmHg at rest resting heart rate greater than 120 beat per min oxygen saturation (SpO2\) less than 95% at rest

Outcomes

Primary Outcomes

Not specified

Similar Trials